Zomedica Disclosure

Zomedica Pharmaceuticals, Corp. (NYSE American: ZOM and TSX Venture Exchange: ZOM.V) is a client of PCG Advisory, Inc. ZOM has an agreement in place to pay PCG a monthly cash fee of $7,500 for PCG investor awareness and investor relations advisory services. Additionally, ZOM paid PCG $18,000 for this initiation report plus 3 quarterly updates, as well as certain investor awareness services related to these reports.

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. PCG investor awareness and advisory services include the preparation of a research profile(s), multimedia marketing, and other awareness services.